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Background: Paediatric tuberculosis (TB) is poorly addressed in Ethiopia and information about its magnitude and
the genotype distribution of the causative Mycobacterium tuberculosis strains responsible for its spread are scanty.
Methods: Gastric lavage or sputum samples were collected from consecutively enrolled TB suspect children visiting
Jimma University Hospital in 2011 and cultured on Middlebrook 7H11 and Löwenstein-Jensen media. Acid fast
bacterial (AFB) isolates were subjected to molecular typing targeting regions of difference (RDs), 16S rDNA gene
and the direct repeat (DR) region using multiplex polymerase chain reaction (mPCR), gene sequencing and
spoligotyping, respectively. Molecular drug susceptibility testing of M. tuberculosis isolates was performed by
Genotype®MTBDRplus line probe assay (LPA) (Hain Life Sciences, Germany).
Results: Gastric lavage (n = 43) or sputum (n = 58) samples were collected from 101 children and 31.7% (32/101) of
the samples were positive for AFB by microscopy, culture and/or PCR. Out of 25 AFB isolates, 60% (15/25) were
identified as M. tuberculosis by PCR, and 40% isolates (10/25) were confirmed to be non-tuberculous mycobacteria
(NTM) by genus typing and 16S rDNA gene sequencing. Lineage classification assigned the M. tuberculosis strains
into Euro-American (EUA, 66.7%; 10/15), East-African-Indian (EAI; 2/15), East-Asian (EA; 1/15) and Indio-Oceanic
(IO; 1/15) lineages. Seven M. tuberculosis strains were new to the SpolDB4 database. All of the M. tuberculosis isolates
were susceptible to isoniazid (INH) and rifampicin (RIF), except for one strain (of spoligotype SIT-149 or T3_ETH
family) which had a mutation at the inhA locus which often confers resistance to INH (low level) and ethionamide.
Conclusions: Analysis of the genetic population structure of paediatric M. tuberculosis strains suggested similarity
with that of adults, indicating an on-going and active transmission of M. tuberculosis from adults to children in
Ethiopia. There were no multidrug-resistant TB (MDR-TB) strains among the isolates.
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Tuberculosis (TB) accounts for more than 10% of hos-
pital admissions and death in children in developing
countries such as Ethiopia [1-3]. The high burden of TB
among children is assumed to be due to the high preva-
lence of TB in adults, HIV co-infection, malnutrition
and other conditions related to poverty [4].
Addressing childhood tuberculosis is important not
only because of the morbidity and mortality burden in
children but also because it is a public health measure of* Correspondence: bekicho@gmail.com
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indicator of the effectiveness of TB control programmes.
TB infection in childhood impacts on future control stra-
tegies as a source of transmission decades later due to re-
activation of latency [5]. Ethiopia is a TB high burden
country (prevalence of 237/100,000 people) with low case
detection rates [6]. Infection among children is likely to be
similarly high since children acquire the disease mainly
from adults [2,7]. The actual magnitude of paediatric TB
is unknown in the country and national reports have so
far provided little information on its prevalence [8].
Molecular characterization of strains has allowed for
the analysis and better understanding of transmission
dynamics, genetic phylogeny, strain virulence and drugentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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molecular methods for simultaneous detection and typ-
ing of M. tuberculosis complex bacteria and the identifi-
cation of epidemiological links between patients [11],
although it has less discriminatory power compared to
the restriction fragment length polymorphism (RFLP)
typing using insertion element IS6110 [12].
Based on large sequence polymorphism, six main lineages
have been described within the M. tuberculosis complex
(MTBC) affecting humans: Indio-oceanic (IO) (Lineage 1),
East-Asian (EA) (Lineage 2), East-African-Indian (EAI)
(Lineage 3), Euro-American (EUA) (Lineage 4), West
African Lineage I (Lineage 5) and West African Lineage
II (Lineage 6) [13]. However, the naming and the group-
ing systems vary according to the molecular marker and
the method of typing used. For example the SpolDB4
system assigns the MTBC organisms into 62 clades/lin-
eages based on the genome variability at the DR locus
(e.g. EAI, Beijing, CAS, Haarlem, T, X, AFRI 1 and AFRI
2) [14]. Gagneux and Small [15] have reviewed the
different terminology and the genetic markers used to
assign the MTBC into different phylogeographic group-
ings. Once the genotype data are available, different
online computer programs and databases can assist in
suggesting and assigning of the MTBC strains into
genetic groups using a set of mathematical rules and
according to the molecular marker used [16-18].
This study aimed to identify the genetic diversity of
Mycobacterium isolates responsible for paediatric TB in
Jimma University Hospital in southwest Ethiopia and
compare this with already described diversity among
adult Ethiopians.
Methods
Study population and area
Jimma University Hospital is located 355 km southwest
of Addis Ababa. The hospital has 300 beds and provides
curative and preventive service for 300–400 patients per
day at its outpatient department [19]. The Paediatric and
Child Health Department of the hospital gives inpatient
and outpatient services to children (<15 years of age)
and provides medical care for more than 100 children
daily in the outpatient (OPD) section. Children under
15 years of age who presented to the OPD with clinically
suspected tuberculosis according to the national guide-
line based on sign symptom complex, chest X-ray and
tuberculin skin test (TST) findings were consecutively
recruited into this study [20] over a period of one year
in 2011.
Ethical clearance
The study was approved by the Ethics Review Boards of
Jimma University, AHRI/ALERT Ethical Review Commit-
tee (Ref No: P015/09), and the National Health ResearchEthics Review Committee (NERC) of the Ethiopian Minis-
try of Science and Technology (Ref No: RDHE/82-92/
2010). Informed consent was obtained from parents or
guardians and additional assent was obtained from chil-
dren older than 12 years of age.
Sample collection and processing
Three sputum samples were collected from each child
able to expectorate sputum. From younger children un-
able to provide sputum, gastric lavage samples were col-
lected in the inpatient department on three consecutive
mornings after an overnight fast. This was done by
inserting a nasogastric tube into the stomach immedi-
ately after the patients woke up in the morning [21]. A
minimum of 30 ml gastric fluid was drawn into a 50 ml
syringe attached to the tube and transferred to a 50 ml
sterile plastic tube. If there was no aspirate, the stomach
was irrigated with 50 ml of sterile physiologic saline and
aspirated back into the syringe. Within 30 minutes of
sample collection, sodium bicarbonate (100 mg of sodium
bicarbonate per 5 to 10 ml of aspirate) was used to
neutralize the sample before storage at −20°C for a ma-
ximum of 2 months until transported on ice to the TB
laboratory of the Armauer Hansen Research Institute
where the samples were further stored at −20°C and
processed for culture within 2 weeks of receipt.
The digestion-decontamination procedure of all col-
lected samples was based on the method developed by
Kubica et al. [22-25]. Briefly, a fresh solution of digestant
was prepared by adding 0.5 mg of NALC powder to
100 ml of sterile NaOH and tri-sodium citrate mixture
(4% NaOH and 2.9% tri-sodium citrate; Sigma). The final
concentration of NaOH in the digestant was 2%. The
samples were decontaminated by adding an equal vol-
ume of fresh digestant in a 50 ml sterile plastic tube for
15 minutes at room temperature, and neutralized by ex-
cess of phosphate buffered saline (PBS) pH 7.2 (Sigma,
Germany). The sample was centrifuged for 15 minutes
at 3200 RCF in a cooling ultracentrifuge. The super-
natant was then discarded aseptically and the pellet re-
suspended in 3 ml sterile PBS buffer.
Culture
Fluka’s TB base medium was used to prepare Löwenstein-
Jensen (LJ) slants according to manufacturer instructions
(Fluka Chemie GmbH, Switzerland). To support the
growth of M. bovis, one of the media contained pyruvate
(Sigma, Germany). Gruft’s mycobacterial supplement
(Fluka Chemie GmbH, Switzerland), which contained
penicillin, nalidixic acid and ribonucleic acid, was asep-
tically added to all LJ media as supplement for the se-
lective cultivation of mycobacteria according to the
manufacturer’s recommendation (Fluka Chemie GmbH,
Switzerland). Agar-base solid media were prepared
Table 1 Clinical and socio-demographic characteristics of
consecutively enrolled childhood TB suspects visiting
Jimma University Hospital, 2011 (n = 121)
Risk factor Category No %
Age (in year) 1–5 52 43
6–10 46 38
11–15 23 19
Sex Male 69 57
Female 52 43
Contact history Yes 67 55
No 54 45
Fever Yes 98 81
No 23 19
Night sweats Yes 103 85
No 18 15
HIV Reactive 15 12
Non-reactive 106 88
Tuberculin skin test 0 mm 65 54
1–10 mm 34 28
>10 mm 22 18
Anthropometry Normal 43 36
Mild malnourished 28 23
Moderate malnourished 29 24
Severe malnourished 21 17
All participants in the study had cough of greater than 2 weeks of duration.
The sign and symptom complex was defined as: night sweats, sweating that
leads to wetting of the bed sheet; fever, body temperature of >37.5°C; close
contact, living in the same household as, or in frequent contact with, a source
case with sputum smear-positive pulmonary TB or clinically diagnosed TB; and
anthropometry were based on weight, height/length and mid-upper arm
circumference (MUAC) measurements and classification of acute malnutrition
is according to Waterlow scheme (weight for height (W/H) (not malnourished,
W/H >90 percent of reference median; mild malnutrition, W/H 80–90 percent
of reference median; moderate acute malnutrition, W/H 70–80 percent of
reference median; and severe acute malnutrition, W/H <70 percent of
reference median).
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ies, USA).
Decontaminated samples were each inoculated on four
LJ (supplemented with either pyruvate or glycerol) and
one 7H11 agar slants. Tubes were incubated at 37°C and
inspected for growth daily for the first week and weekly
thereafter for eight weeks. Suspected colonies were
tested for AFB by Ziehl-Neelsen staining and positive
isolates were characterized by molecular techniques de-
scribed below.
Species identification
Isolates were heat killed by suspending 2–3 AFB
colonies in 500 μl distilled water in a test tube and
heated at 95°C submerged in an ultrasonic water bath
for 1 hour. A set of six primers were used in a multiplex
PCR to determine isolates for genus Mycobacterium, M.
tuberculosis complex, M. intracellulare and M. avium in
a single PCR assay according to Wilton and Cousins
[26]. Isolates were considered as non-tuberculous myco-
bacteria (NTM), if they were identified as mycobacteria
that did not belong to the MTBC by this multiplex PCR
method. These organisms were subjected to 16S rDNA
sequencing for species identification; the PCR method,
amplification and detection conditions have been
described previously [27]. For isolates identified as
MTBC, an additional set of 3 primers targeting Region
of Difference 9 (RD9) was performed to differentiate M.
tuberculosis from other members of the MTBC.
Spoligotyping
MTBC organisms confirmed by RD9 typing were further
characterized by spoligotyping. The procedure involved
heat killing isolates, PCR amplification of spacers in the
DR locus and detection according to previously de-
scribed protocol [10]. M. tuberculosis H37Rv, M. bovis
BCG and Qiagen RNAse free water was included as
positive and negative controls. The spoligotyping data
was analyzed using spolTools program [28].
GenoType®MTBDRplus assay
Sensitivity of the isolated M. tuberculosis strains to isonia-
zid (INH) and rifampicin (RIF) was tested with the
GenoType®MTBDRplus line probe assay (LPA) performed
according to the manufacturer’s protocol (Hain Life
Science GmbH, Germany).
Results
Characteristics of the study participants
A total of 121 participants were included in this study
and the male to female ratio was 1.3. The age of the pa-
tients ranged from one to fifteen with a mean age of
6.5 years. Forty three percent (52/121) of the partici-
pants were under 5 years of age (Table 1). All of theparticipants had a clinical diagnosis of TB according to
the national algorithm based on a combination of clinical
and laboratory findings (including cough of ≥ 2 weeks
duration, contact history, tuberculin skin test positivity
and chest X-ray). There was no sample for analysis from
20 participants (16.5%) due to withdrawal or laboratory
rejection of gastric lavage samples containing food parti-
cles. Among the 101 cases for whom samples were avai-
lable, 58 (57.4%) had provided sputum and 43 (42.6%)
gastric lavage.
AFB microscopy and culture
Two hundred and thirty samples from 101 patients (on
average 2.3 samples from each child) were processed
separately by culture and microscopy. Specimens from
the same patient were considered together for analysis
and a patient was considered positive when any one of
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teria. Smear microscopy was positive for AFB in 18/101
(17.8%) and mycobacterial isolates were detected in 25/
101 (24.6%) patients. Gastric lavage was positive for AFB
microscopy in 11 patients and culture yielded isolates in
10 cases (Figure 1).
Molecular analysis
The 25 AFB organisms isolated on culture were further
characterized by molecular typing. Genus typing re-
vealed that all AFB isolates belonged to the genus Myco-
bacterium; 60% (15/25) were isolates from the MTBC
and the remaining strains (10/25; 40%) were typed as
NTM. 16S rDNA sequence analysis of the NTM isolates
suggested M. fortuitum/M. porcinum, M. triviale, M.
parascrofulaceum/M. seoulense/M. gastri/M. kansasii/M.
nebraskense, M. fortuitum, M. terrae, M. engbackii and
M. confluentis as the most likely species (Figure 2A).
Further analysis of the MTBC strains identified all of them
as M. tuberculosis, intact for the RD9 region (Figure 2B).
Spoligotyping of these M. tuberculosis isolates showed that
eight belonged to Shared International Type (SIT) number
37, 53, 149, 817, 289 and 120 according to the SpolDB4
database nomenclature [14], while the remaining 7 strains
were new to this database. Using the Run TB-Lineage pro-
gram, all (100%) of the M. tuberculosis strains could be ac-
curately categorized into one of the CDC’s TB lineages:
Euro-American (EUA, 66.7%; 10/15), East-African-Indian
(EAI; 2/15) and East-Asian (EA; 1/15), and one strainTotal Patients Enrolled; 
#Pt. Sample Collec
n= 101
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Figure 1 Results from bacteriological and molecular analysis of gastri
Jimma University Hospital, Ethiopia, in 2011.(PST-04) probably belonging to the Indio-Oceanic (IO; 1/
15) lineage with a probability of 0.94 (Figure 3). All of the
M. tuberculosis strains tested for drug resistance were
found to be susceptible to INH and RIF except for one
strain (of spoligotype SIT-149 or T3_ETH family) that had
mutation at the inhA locus which often confers resistance
to INH (low level) and ethionamide.
Discussion
The actual burden of childhood tuberculosis is unknown
due to lack of routine case records and difficulty of diag-
nosing TB in children, both clinically and bacteriologic-
ally. However, it is estimated that in countries with high
burden of TB up to 25% of the TB cases occur in children
[6]. Thus, childhood tuberculosis represents a significant
but still neglected clinical and public health problem [29].
Epidemiologically, investigation into paediatric TB is po-
tentially more informative than adult TB in order to
understand the status of recent transmission, evaluate ef-
fectiveness of TB control programmes or predict future
trends in TB transmission [5]. Molecular tools such as
spoligotyping have been standardized and widely used for
species identification and depiction of the genetic diversity
of MTBC organisms [10]. Using these tools, we characte-
rized the clinical isolates of M. tuberculosis from paediat-
ric patients in the Jimma area of south west Ethiopia and
categorized them into previously established MTBC ge-
netic groupings [14,30]: 10 strains as belonging to Lineage 4
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c lavage and sputum samples from pediatric TB suspects at
Figure 2 Gel electrophoresis of multiplex Genus (A) and RD9 (B) typing for isolates of Mycobacterium species. A: The multiplex Genus
typing method used defines the genus Mycobacterium, MTBC, M. avium and M. intracellulare. Expected PCR Product for Mycobacterium genus, M.
intracellulare, MTBC and M. avium were 1030 bp, 850 bp, 372 bp and 180 bp respectively. Lane 1, 100 bp DNA ladder; Lanes 2–9, selected isolates
(Lanes 2–4, 6, 8, 9, isolates identified as of Mycobacterium genus; Lanes 2–4, 8, 9, isolates of MTBC; Lane 6, isolate of NTM); Lane 10–12, controls
(Lane 10, M. tuberculosis H37Rv; Lane 11, M. bovis BCG; Lane 12, Negative control. B: RD9 typing showing expected PCR products for M.
tuberculosis (RD9 intact, 396 bp) and for MTBC members other than M. tuberculosis (RD9 deleted, 575 bp). Lane 1 and 12, 100 bp DNA ladder;
Lanes 2–8, selected isolates (Lanes 2 and 7, no PCR product (not of MTBC); Lane 3–6, 8, identified as M. tuberculosis; Lane 9–11, controls
(M. tuberculosis H37Rv; Lane 10, negative control (H2O Qiagen); Lane 11, M. bovis AF2122/97.
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Interestingly, gastric lavage specimens were positive for AFB
on smear microscopy at similar proportions as culture pos-
sibly due to limited survival of the bacilli in the acidic envi-
ronment of gastric lavage.
It is well established that MTBC strains have a clonal
genetic population structure and are highly restricted to
geographical regions [15]. Firdessa et al. [31] reported
the genetic population structure of the MTBC from an
Ethiopian adult population that was predominantlyFigure 3 Spoligotype pattern of M. tuberculosis strains isolated from
pattern of M. tuberculosis isolated from 14 children (one M. tuberculosis stra
(SPOLDB4) and SPOT CLUST grouping. H4, Haarlem; CAS1_DELHI, The Cent
Indo-Oceanic; EAI, East-African-Indian; PST, Orphan paediatric Spoligotype.composed of EUA (Lineage 4) and EAI (CAS, according
to SpolDB4; Lineage 3). In agreement with that report,
most of the strains isolated in this small series belonged
to Lineage 4 (EUA) (60%) and Lineage 3 or EAI/CAS
(13%). As far as can be concluded from the relatively
few numbers and the single geographic area of recruit-
ment, it seems that the population structure of our
paediatric M. tuberculosis strains parallels that of the
adult TB patients in Ethiopia. The contrary is possible as
illustrated in a report on paediatric strains from Mexico,children with suspected TB in Jimma, Ethiopia, 2011. Spoligotype
in failed), also showing the corresponding SIT no, the family label
ral Asian sub-lineage; EUA, Euro-American; EA, East-Asian; IO,
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TB patients in one particular state [32]. This fact sug-
gests active transmission of TB from adults to children
in Ethiopia, since children mainly acquire the disease
from adults. Unlike our dataset, genotyping of isolates
from 400 culture positive children in South Africa had
identified the most contagious and virulent Beijing
lineage to be the predominant strain in both paediatric
[33] and adult South African patients [34].
High proportions (46.7%; 7/15) of the spoligotypes
from our study children were orphan patterns, i.e., pat-
terns not previously reported to the international data-
base of SpolDB4 (SITVIT2 database) [14]. This finding
suggests that the diversity of spoligotype patterns in
Ethiopia is not fully explored. A report on Mexican
children had also identified that up to 34.5% of the
spoligotype patterns were orphan to the SITVIT2 data-
base [32]. Construction of an MTBC strain database
dedicated to paediatric isolates would be beneficial for
research on TB in children. The clinical spectrum of
disease and diagnostic approaches of childhood TB are
different from those of adults and the two may need to
be addressed separately [35].
Two thirds of the rapidly growing mycobacterial iso-
lates from clinical specimens could cause true to prob-
able infections and most of them could be isolated
from respiratory sites. A large proportion of the pa-
tients with respiratory NTM isolates have underlying
lung injuries and co-isolation of other pathogenic mi-
croorganisms such as the M. fortuitum complex group
(M. fortuitum, M. porcium and others) is common [36].
The M. fortuitum group has also been isolated from re-
spiratory samples of children in our study (2/7; 28.5%).
M. kansasii is a slow growing mycobacterium com-
monly found in tap water rather than in soil or salt
water and consequently, M. kansasii related disease oc-
curs in areas where contaminated drinking water is
found [37]. Our M. kansasii isolate from gastric lavage
could be a contaminant from the hospital tap water or
an opportunistic nosocomial pathogen in children with
a weakened resistance. An assessment of the myco-
bacteriology of the hospital environment might help
clarify the source.
No multidrug-resistant TB (MDR-TB) strain was
detected among the 25 paediatric TB isolates tested in
this study. There was one INH-resistant strain (4%). A
study on adults in the same hospital in 2010 reported a
1.5% rate of multi-drug resistance and 13.4% INH re-
sistance [38]. Although MDR TB appears to be rare
among children at the site, the presence of MDR TB in
the area albeit at relatively low proportions should alert
health workers to the risk of MDR TB in children
complicating care in an already difficult diagnostic
environment.Conclusions
Genetic typing of MTBC strains isolated from childhood
TB patients in Jimma showed that the same lineages that
dominate among adults, Lineages 4 and 3 (EUA and EAI
or CAS), are prominent in children, suggesting on-going
transmission of TB from adults to children in the area.
A high proportion of strains were also unique to the
SpolDB4 database and this calls for further studies to ex-
plore MTBC strains causing childhood TB in Ethiopia
on a larger scale. To this end, constructing and populat-
ing a database dedicated to MTBC strains isolated from
children is of potentially significant impact in under-
standing and monitoring the epidemiology of TB in chil-
dren in this high burden country.
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